相关实验视频

Updated: Jun 25, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

在2021年波兰的结核病

Maria Korzeniewska-Koseła¹, Stefan Wesołowski¹

¹National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.

Przeglad epidemiologiczny

|May 24, 2024

概括

与2020年相比,2021年波兰结核病发病率上升了10.2%,比2020年增加了10.2%. 波兰报告的细菌学确认率高,多抗药结核病 (MDR-TB) 率低于欧盟/欧洲经济区的平均水平.

科学领域:

公共卫生公共卫生
流行病学流行病学
传染性疾病传染性疾病

背景情况:

结核病 (TB) 仍然是一个重大的全球卫生挑战.
了解结核病的流行病学对于有效的控制策略至关重要.
波兰的结核病情况需要在欧洲趋势的背景下进行分析.

研究的目的:

评估2021年波兰结核病的主要流行病学特征.
将波兰的结核病数据与欧盟和欧洲经济区 (EU/EEA) 国家的结核病数据进行比较.

主要方法:

分析国家结核病例数据,包括药物敏感性.
包括来自波兰统计局的死亡率数据和HIV-TB同时感染的数据.
利用了欧洲疾病预防控制中心和世界卫生组织的数据.

主要成果:

波兰在2021年报告了3704起结核病病例,每10万人口中发生率为9.7.
肺结核占95.9%的病例;1.9%的人患有多抗药性结核病 (MDR-TB).
男性 (14.6/100,000) 的发病率高于女性 (5.1/100,000) 的发病率,并且随着年龄的增长而增加.

结论:

波兰的结核病发病率从2020年到2021年增加了10.2%.
与欧盟/欧洲经济区平均水平相比,波兰的细菌学确认率更高 (82.6%) 和MDR-TB率更低 (1.9%).
与欧盟/欧洲经济区国家相比,波兰显示移民对结核病流行病学的影响较小.

关键词:

在MDR-TB中,使用的是MDR.结核病通过培养得到证实.结核病发病率结核病发生率格鲁兹利卡石是土壤中的一种.确认细菌学的情况.结核病 (TB) 是一种疾病.这就是Zapadalność的意义.

更多相关视频

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection

Published on: September 18, 2020

相关概念视频

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.